Form 15-12G - Securities registration termination [Section 12(g)]
15 Noviembre 2024 - 3:12PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-39951
Peak Bio Inc.
(Exact name of registrant as specified in its charter)
4900 Hopyard Road, Suite 100
Pleasonton, CA, 94588
(925) 463-4800
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par value $0.0001 per share
Warrants to purchase common stock at an exercise price of $11.50 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1) |
|
☒ |
Rule 12g-4(a)(2) |
|
☐ |
Rule 12h-3(b)(1)(i) |
|
☒ |
Rule 12h-3(b)(1)(ii) |
|
☐ |
Rule 15d-6 |
|
☐ |
Rule 15d-22(b) |
|
☐ |
Approximate number of holders of record as of the certification or notice date: one (1).
Pursuant to the requirements of the Securities Exchange Act of 1934, Peak Bio Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date: November 15, 2024 |
|
|
|
PEAK BIO INC. |
|
|
|
|
|
|
|
|
By: |
|
/s/ Samir Patel, M.D. |
|
|
|
|
Name: |
|
Samir Patel, M.D. |
|
|
|
|
Title: |
|
President and Secretary |
Peak Bio (PK) (USOTC:PKBOW)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Peak Bio (PK) (USOTC:PKBOW)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Peak Bio Inc (PK) (OTCMarkets): 0 recent articles
Más de Peak Bio Inc (PK) Artículos de Noticias